Holen Sie sich die Stockscreener-App
9.20
3.27%
-0.28
Finanzdaten der Vir Biotechnology Inc-Aktie (VIR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
26,596%
64.07
|
0.24 | 1.214 | 3.032 | 2.38 |
Operating Expenses
|
35.53%
111.97
|
173.68 | 119.62 | 142.58 | 233.63 |
| Benefits Costs and Expenses |
34.36%
107.13
|
163.21 | 112.00 | 123.98 | 215.92 |
| Costs And Expenses |
35.52%
111.99
|
173.68 | 119.63 | 142.58 | 233.68 |
| Operating Income/Loss |
72.37%
-47.92
|
-173.44 | -118.42 | -139.55 | -231.30 |
| Nonoperating Income/Loss |
53.57%
4.861
|
10.47 | 7.629 | 18.60 | 17.76 |
| Income/Loss From Continuing Operations Before Tax |
73.58%
-43.06
|
-162.97 | -110.79 | -120.95 | -213.54 |
| Income Tax Expense/Benefit |
181.55%
-0.137
|
0.168 | 0.17 | 0.016 | 0.177 |
| Income/Loss From Continuing Operations After Tax |
73.69%
-42.92
|
-163.14 | -110.96 | -120.97 | -213.72 |
|
Net Income/Loss
|
73.69%
-42.92
|
-163.14 | -110.96 | -120.97 | -213.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.83%
0.2329
|
138.93 | 138.45 | 137.47 | 136.65 |
| Diluted Average Shares |
99.83%
0.2329
|
138.93 | 138.45 | 137.47 | 136.65 |
| Basic Earnings Per Share |
74.36%
-0.30
|
-1.17 | -0.80 | -0.88 | -1.56 |
| Diluted Earnings Per Share |
74.36%
-0.30
|
-1.17 | -0.80 | -0.88 | -1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):